Surgical resection versus liver transplant for patients with hepatocellular carcinoma

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Taefi, Amir ^a   Abrishami, Amir ^b   Nasseri Moghaddam, Siavosh ^c   Eghtesad, Bijan ^d   Sherman, Morris ^e  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d LERNER RESEARCH INSTITUTE   (United States)

^e TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SURGERY; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; LIVER NEOPLASMS;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 84891712986     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006935.pub2     Document Type: Review

References (110)

1. Bartlett AJR, McCall JL, Koea JB, Holden A, Yeong ML, Gurusinghe N, et al.Liver resection for hepatocellular carcinoma in a hepatitis B endemic area. World Journal of Surgery 2007;31:1775-81.
2. Bartlett A, Heaton N. Hepatocellular carcinoma: Defining the place of surgery in an era of organ shortage. World Journal of Gastroenterology 2008;14(28):4445-53.
3. Belghiti J, Cortes A, Abdalla EK, Regimbeau JM, Prakash K, Durand F, et al.Resection prior to liver transplantation for hepatocellular carcinoma. Annals of Surgery 2003;238:885-92.
4. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Annals of Surgery 1993;218(2):145-51.
5. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al.A prospective randomised trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Annals of Surgery 2006;243(3):321-8.
6. Choti MA. Surgical management of hepatocellular carcinoma: resection and ablation. Journal of Vascular Interventional Radiology 2002;13:197-203.
7. Chung SW, Toth JL, Rezieg M, Cameron R, Taylor BR, Greig PD, et al.Liver transplantation for hepatocellular carcinoma. American Journal of Surgery 1994;167:317-21.
8. Colleoni M, Audisio RA, De Braud F, Fazio N, Martinelli G, Goldhirsch A. Treatment of hepatocellular carcinoma. Drugs 1998;55(3):367-82.
9. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, et al.Impact of UCSF criteria according to pre- and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time. Liver Transplantation 2006;12:1761-9.
10. Ercolani G, Grazi GL, Ravaioli M, Massimo DG, Gardini A, Cescon M, et al.Liver resection for hepatocellular carcinoma on cirrhosis. Annals of Surgery 2003;237:536-43.
11. Fan ST, Ng IOL, Poon RTP, Lo CML, Liu CL, Wong J. Hepatectomy for hepatocellular carcinoma. Archives of Surgery 1999;134:1124-30.
12. Figueras J, Ibanez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, et al.Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transplantation 2001;7(10):877-83.
13. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a western center. Annals of Surgery 1999;229(6):799-800.
14. Huang ZY, Chen G, Hao XY, Cai RY, Zhao YF, Chen XP. Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors. Langenbeck's Archives of Surgery 2011;396(2):193-9.
15. Hwang S, Lee SG, Joh JW, Sub KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transplantation 2005;11(10):1265-72.
16. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T, et al.Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33(5):1080-6.
17. Jonas S, Mittler J, Pascher A, Schumacher G, Theruvath T, Benckert C, et al.Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center. Liver Transplantation 2007;13:896-903.
18. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma. Cancer 1998;82:1028-36.
19. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-40.
20. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. New England Journal of Medicine 1996;334(11):693-9.
21. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, et al.Liver resection for hepatocellular carcinoma. Annals of Surgery 1993;217(4):375-84.
22. Nuzzo G, Giuliante F, Gauzolino R, Vellone M, Giovannini I. Liver resections for hepatocellular carcinoma in chronic liver disease: experience in an Italian centre. European Journal of Surgical Oncology 2007;33:1014-8.
23. Sim HG, Ooi LLPJ. Results of resections for hepatocellular carcinoma in a new hepatobiliary unit. Australian and New Zealand Journal of Surgery 2003;73:8-13.
24. Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma. Annals of Surgery 2004;240:451-61.
25. Yao FY, Ferrell L, Bass NM, Watson JJ, Bachetti P, Venook A, et al.Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33(6):1394-403.
26. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al.Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy. Annual of Surgery 2003;238(4):518-9.
27. Badvie S. Hepatocellular carcinoma. Postgraduate Medical Journal 2000;76:4-11.
28. Bain I, McMaster P. Benign and malignant liver tumours. Surgery 1997;15:169-74.
29. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Peri-operative beta-blockers in patients undergoing non-cardiac surgery. A meta-analysis and trial sequential analysis of 12, 306 patients from randomised trials. Lancet 2008;372:1962-76.
30. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50(4):1088-101.
31. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Annals of Surgery 1991;214(2):114-7.
32. Bhoori S, Schiavo M, Russo A, Mazzaferro V. First-line treatment for hepatocellular carcinoma: resection or transplantation?. Transplantation Proceedings 2007;39(7):2271-3.
33. Blum HE. Hepatocellular carcinoma: therapy and prevention. World Journal of Gastroenterology 2005;11(47):7391-400.
34. Bosch FX. Primary liver cancer. Gastroenterology 2004;127:S5-S16.
35. Botha JF, Grant WJ, Shaw BW. Surgical options for the treatment of hepatocellular carcinoma. In: Schiff ER, Sorrell MF, Maddrey WC editor(s). Schiff's Diseases of the Liver. 10th Edition. Vol. 2, Philadelphia: Lippincott Williams & Wilkins, 2007:1266-71.
36. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61:763-9.
37. Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive - Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98.
38. Bruix J. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Gastroenterology 1996;111:1018-22.
39. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-35.
40. Bruix J, Hessheimer AJ. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 2006;25:3848-56.
41. Buyse M, Ryan LM. Issues of efficiency in combining proportions of deaths from several clinical trials. Statistics in Medicine 1987;6:565-76.
42. Capussotti L, Muratore A, Amisano M, Massucco P, Polastri R, Bouzari H. Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patients - no mortality and long-term survival. Hepato-Gastroenterology 2006;53(71):768-72.
43. Carr BI. Tumors of the liver and biliary tree. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J editor(s). Harrison's Principle of Internal Medicine (http://www.accessmedicine.com/content.aspx?aID=9116154). 18th Edition. New York: McGraw-Hill, 2012 (accessed January 17, 2013):Chapter 92.
44. Clark HP. Staging and current treatment of hepatocellular carcinoma. Radiologic Graphics 2005;25:S3-S23.
45. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-8.
46. Copenhagen Trial Unit. TSA - Trial Sequential Analysis. http://ctu.dk/tsa/ 2011 (accessed 26 June 2013).
47. DeMets DL. Methods for combining randomised clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
48. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
49. Deuffic S. Trends in primary liver cancer. Lancet 1998;351:214-5.
50. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
51. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatology Research 2007;37(Suppl 2):S88-S94.
52. Farmer DG, Rosove MH. Current treatment modalities for HCC. Annual of Surgery 1994;219:236-47.
53. Galandi D, Antes G. Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003046.pub2]
54. Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 5. Art. No.: LIVER.
55. Grazi GL, Ercoliani G. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Annual of Surgery 2001;234(1):71-8.
56. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
57. Hwang S, Lee SG, Moon DB, Ahn CS, Kim KH, Lee YJ, et al.Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transplantation 2007;13:741-6.
58. International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines. Vol. 1, PA 19063-2043, USA: Barnett International/PAREXEL, 1997.
59. Kim WR, Therneau TM, Benson JT. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology 2006;43(2):345-51.
60. Kjaergard LL, Villumsen J, Gluud C. Reported methodological quality and discrepancies between large and small randomised trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
61. Kwon CHD, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, et al.HCC in living donor liver transplantation: can we expand the Milan criteria?. Digestive Diseases 2007;25:313-9.
62. Lencioni R, Pinto F, Bassi AM, Moretti M, Di Giulio M, Marchi S, et al.Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: an European experience. European Radiology 1997;7:514-9.
63. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al.Small hepatocellular carcinoma in cirrhosis: randomised comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228(1):235-40.
64. Lencioni R, Cioni D. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005;234(3):961-7.
65. Li HY, Wei YG, Yan LN, Li B. Salvage liver transplantation in the treatment of hepatocellular carcinoma: a meta-analysis. World Journal of Gastroenterology 2012;18(19):2415-22.
66. Liu JH, Chen PW. Surgery for hepatocellular carcinoma: does it improve survival?. Annals of Surgical Oncology 2004;11:298-303.
67. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolodi L, et al.Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197(1):101-8.
68. Llovet JM. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
69. Llovet JM. Updated treatment approach to hepatocellular carcinoma. Journal of Gastroenterology 2005;40:225-35.
70. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2]
71. Marin-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Critical Reviews in Oncology/Hematology 2003;47(1):13-27.
72. Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transplant Immunology 2007;17(2):114-9.
73. McCormack L. Surgical therapy of hepatocellular carcinoma. Europian Journal of Gastroenterology and Hepatology 2005;17(5):497-503.
74. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352:609-13.
75. Nagasue N, Yukay H. Clinical experience with 118 hepatic resections for HCC. Surgery 1986;99:694-701.
76. Nagorney DM, van Heerden JA. Primary hepatic malignancy: surgical management and determinants of survival. Surgery 1989;106(4):740-8.
77. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection. Hepatology 1996;24:1379-85.
78. Ohnishi K, Yoshioka H, Ito S, Fujiwara K. Prospective randomised controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998;27:67-72.
79. Okuda K. Where we go with hepatocellular carcinoma: past, present, and future perspectives. Journal of Hepato-Biliary-Pancreatic Surgery 2002;9(6):683-5.
80. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transplant 2007;13:391-9.
81. Paquet KJ. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study. British Journal of Surgery 1991;78(4):459-62.
82. Paraskevopoulos JA. Management options for primary HCC. An overview. Acta Oncologica 1994;33:895-900.
83. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
84. Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transplantation 2004;10(2 Suppl 1):S39-S45.
85. Popescu I, Ionescu M, Ciurea S, Brasoveanu V, Sarbu-Boeti P, Hrehoret D, et al.Current treatment of hepatocellular carcinoma. Analysis of a series of 123 cases over a 5-year period. Chirurgia 2005;100(4):321-31.
86. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
87. Ribero D, Abdalla EK, Thomas MB. Liver resection in the treatment of hepatocellular carcinoma. Expert Review of Anticancer Therapy 2006;6(4):567-79.
88. Royle P, Milne R. Literature searching for randomised controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
89. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al.Influence of reported study design characteristics on intervention effect estimates from randomised, controlled trials. Health Technology Assessment 2012;16(35):1-82.
90. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al.Influence of reported study design characteristics on intervention effect estimates from randomised, controlled trials. Annals of Internal Medicine 2012;157(6):429-38.
91. Schoppmeyer K, Wagner AD, Mossner J, Fleig W. Percutanous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD006745]
92. Schulz KF, Chalmers I. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
93. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Seminars in Liver Disease 2005;25(2):143-54.
94. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima A, Terashi T. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007;83:893-9.
95. Song TJ, Ip EW, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology 2004;127(5 Suppl 1):S248-S260.
96. Sotiropoulos GC, Lang H, Frilling A. Resectability of hepatocellular carcinoma: evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature. Hepato-Gastroenterology 2006;53(69):322-9.
97. Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Digestive Diseases 2007;25:310-2.
98. Takayama T. Early hepatocellular carcinoma as an entity with high rate surgical rate. Hepatology 1998;28:1241-6.
99. Takayama T. Adoptive immunotherapy to lower postsurgical recurrence rate of hepatocellular carcinoma. Lancet 2000;359:1734-9.
100. Taylor-Robinson SD. Increase in primary liver cancer in the UK, 1979-1994. Lancet 1997;350:1142-3.
101. Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al.Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses. International Journal of Epidemiology 2009;38(1):276-86.
102. Thorlund K, Anema A, Mills E. Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology 2010;2:57-66.
103. Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). http://ctu.dk/tsa/files/tsa_manual.pdf 2011 (accessed 23 April 2013).
104. Verhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN. Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Digestive Surgery 2004;21(5-6):380-6.
105. Wallner I, Hartmann H. Current therapeutic strategies in HCC, Part 1. Leber, Magen, Darm 1994;24:150-4.
106. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75.
107. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Medical Research Methodology 2009;9:86.
108. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Resarch Ed.) 2008;336:601-5.
109. Wu L, Hu A, Tam N, Zhang J, Lin M, Guo Z, He X. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection. PLoS ONE 2012;7(7):e41820.
110. Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. Journal of Surgical Oncology 2002;81(4):195-202.